The value of PET compared to MRI in malignant head and neck tumors

Anticancer Research

Volumn 33, Issue 3, 2013, Pages 1141-1146

  Guenzel, Thomas ^a   Franzen, Achim ^a   Wiegand, Susanne ^a   Kraetschmer, Sabine ^a   Ludwig Jahn, Johann ^a   Mironczuk, Robert ^a   Wilhelm, Thomas ^a   Schrom, Thomas ^a  

^a Department of Otorhinolaryngology Head and Neck Surgery ^*  (Germany)

Author keywords

Head and neck cancer; MRI; PET

Indexed keywords

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER OF UNKNOWN PRIMARY SITE; CANCER RECURRENCE; CANCER SIZE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; ENDOSCOPY; FALSE NEGATIVE RESULT; FEMALE; HEAD AND NECK CARCINOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; WHOLE BODY PET;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES;

EID: 84875881053     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM and Wong HF: 18F-FDG-PET and CT/MRI in oral cavity squamous cell carcinoma: A prospective study of 124 patients with histologic correlation. J Nucl Med 46: 1136-1143, 2005.
2. Manavis J, Sivridis L and Koukourakis MI: Nasopharyngeal carcinoma: the impact of CT-scan and of MRI on staging, radiotherapy treatment planning, and outcome of the disease. Clin Imaging 29: 128-133, 2005.
3. Schoder H, Carlson DL, Kraus DH, Stambuk HE, Gonen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM and Wong RJ: 18F-FDG-PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 47: 755-762, 2006.
4. Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG and Brizel DM: Analysis of pretreatment FDGPET SUV parameters in head-and-neck cancer: Tumor SUV mean has superior prognostic value. Int J Radiat Oncol Biol Phys 82: 548-553, 2012.
5. Nguyen NC, Kaushik A, Wolverson MK and Osman MM: Is there a common SUV threshold in oncological FDG-PET/CT, at least for some common indications? A retrospective study. Acta Oncol 50: 670-677, 2011.
6. Carvalho AL, Nishimoto IN, Califano JA and Kowalski LP: Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database. Int J Cancer 114: 806-816, 2005.
7. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer Statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
8. Ries LAG, Harkins D and Krapcho M. SEER Cancer Statistics Review, 1975-2003, National Cancer Institute, Bethesda.
9. Bruschini P, Giorgetti A, Bruschini L, Nacci A, Volterrani D, Cosottini M, Ursino F, Mariani G and Fattori B: Positron-emission tomography (PET) in the staging of head neck cancer: Comparison between PET and CT. Acta Otorhinolaryngol Ital 23: 446-453, 2003.
10. Dammann F, Horger M, Mueller-Berg M, Schlemmer H, Claussen CD, Hoffman J, Eschmann S and Bares R: Rational diagnosis of squamous cell carcinoma of the head and neck region: Comparative evaluation of CT, MRI, and 18FDG-PET. Am J Roentgenol 184: 1326-1331, 2005.
11. Di Martino E, Nowak B, Hassan HA, Hausmann R, Adam G, Buell U and Westhofen M: Diagnosis and staging of head and neck cancer: A comparison of modern imaging modalities (positronemission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 126: 1457-1461, 2000.
12. Dresel S, Grammerstorff J, Schwenzer K, Brinkbaumer K, Schmid R, Pfluger T and Hahn K: [18F]FDG imaging of head and neck tumors: Comparison of hybrid PET and morphological methods. Eur J Nucl Med Mol Imaging 30: 995-1003, 2003.
13. Hannah A, Scott AM, Tochon-Danguy H, Chan JG, Akhurst T, Berlangieri S, Price D, Smith GJ, Schelleman T, McKay WJ and Sizeland A: Evaluation of 18F-fluorodeoxyglucose positronemission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg 236: 208-217, 2002.
14. Guntinas-Lichius O, Peter Klussmann J, Dinh S, Dinh M, Schmidt M, Semrau R and Mueller RP: Diagnostic work-up and outcome of cervical metastases from an unknown primary. Acta Otolaryngol 126: 536-544, 2006.
15. Jereczek-Fossa BA, Jassem J and Orecchia R: Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 30: 153-164, 2004.
16. Johansen J, Eigtved A, Buchwald C, Theilgaard SA and Hansen HS: Implication of 18F-fluoro-2-deoxy-D-glucose positronemission tomography on management of carcinoma of unknown primary in the head and neck: A Danish cohort study. Laryngoscope 112: 2009-2014, 2002.
17. Weber A, Schmoz S and Bootz F: CUP (carcinoma of unknown primary) syndrome in head and neck: Clinic, diagnostic, and therapy. Onkologie 24: 38-43, 2001.
18. Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N, Yoshida M and Yonekura Y: Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 44: 198-206, 2003.
19. Kondo N, Tsukuda M and Nishimura G: Diagnostic sensitivity of 18Fluorodeoxyglucose positron-emission tomography for detecting synchronous multiple primary cancers in head and neck cancer patients. Eur Arch Otorhinolaryngol 269: 1503-1507, 2012.
20. Kresnik E, Mikosch P, Gallowitsch HJ, Kogler D, Wiesser S, Heinisch M, Unterweger O, Raunik W, Kumnig G, Gomez I, Grunbacher G and Lind P: Evaluation of head and neck cancer with 18F-FDG PET: A comparison with conventional methods. Eur J Nucl Med 28: 816-821, 2001.
21. Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M and Fukuda H: FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radiochemotherapy: Comparison with MRI/CT. Eur J Nucl Med Mol Imaging 31: 590-595, 2004.
22. Regelink G, Brouwer J, de Bree R, Pruim J, van der Laan BF, Vaalburg W, Hoekstra OS, Comans EF, Vissink A, Leemans CR and Roodenburg JL: Detection of unknown primary tumors and distant metastases in patients with cervical metastases: Value of FDG-PET versus conventional modalities. Eur J Nucl Med Mol Imaging 29: 1024-1030, 2002.
23. Stuckensen T, Kovacs AF, Adams S and Baum RP: Staging of the neck in patients with oral cavity squamous cell carcinomas: A prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 28: 319-324, 2000.
24. de Bree R: The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour. Eur Arch Otorhinolaryngol 267: 1653-1655, 2010.
25. Bohuslavizki KH, Klutmann S, Kroger S, Sonnemann U, Buchert R, Werner JA, Mester J and Clausen M: FDG-PET detection of unknown primary tumors. J Nucl Med 41: 816-822, 2000.
26. Bohuslavizki KH, Klutmann S, Sonnemann U, Thoms J, Kroger S, Werner JA, Mester J and Clausen M: F-18-FDG-PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region. Laryngorhinootol 78: 445-449, 1999.
27. Werner JA, Dunne AA and Myers JN: Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma. Head Neck 25: 322-332, 2003.
28. Werner JA: Patterns of metastasis in head and neck cancer. Cancer Treat Res 135: 203-207, 2007.
29. Liao LJ, Lo WC, Hsu WL, Wang CT and Lai MS. Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck a meta-analysis comparing different imaging modalities. BMC Cancer 12: 236, 2012.
30. Porceddu SV, Pryor DI, Burmeister E, Burmeister BH, Poulsen MG, Foote MC, Panizza B, Coman S, McFarlane D and Coman W: Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head Neck 33: 1675-1682, 2011.
31. Schoder H, Fury M, Lee N and Kraus D: PET monitoring of therapy response in head and Neck squamous cell carcinoma. J Nucl Med 50(Suppl 1): 74S-88S, 2009.
32. Kunkel M, Grotz KA, Forster GJ, Wahlmann U, Benz P, Kutzner J, Rippins G and Wagner W: Therapy monitoring with 2-(18F)-FDG positron-emission tomography after neoadjuvant radiation treatment of mouth carcinoma. Strahlenther Onkol 177: 145-152, 2001.
33. Nieder C, Gregoire V and Ang KK: Cervical lymph node metastases from occult squamous cell carcinoma: Cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 50: 727-733, 2001.
34. Facey K, Bradbury I, Laking G and Payne E: Overview of the clinical effectiveness of positron-emission tomography imaging in selected cancers. Health Technol Assess 11: iii-iv, xi-267, 2007.
35. Han A, Xue J, Hu M, Zheng J and Wang X: Clinical value of (18)F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary. Cancer Epidemiol 36: 470-475, 2012.
36. Kubicek GJ, Champ C, Fogh S, Wang F, Reddy E, Intenzo C, Dusing RW and Machtay M: FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head Neck Oncol 2: 19, 2010.
37. Loeffelbein DJ, Souvatzoglou M, Wankerl V, Martinez-Moller A, Dinges J, Schwaiger M and Beer AJ: PET-MRI fusion in head-and-neck oncology: Current status and implications for hybrid PET/MRI. J Oral Maxillofac Surg 70: 473-483, 2012.
38. Johansen J, Petersen H, Godballe C, Loft A and Grau C: FDGPET/CT for detection of the unknown primary head and neck tumor. Q J Nucl Med Mol Imaging 55: 500-508, 2011.
39. Ozer E, Naiboǧlu B, Meacham R, Ryoo C, Agrawal A and Schuller DE: The value of PET/CT to assess clinically negative necks. Eur Arch Otorhinolaryngol 269: 2411-2414, 2012.
40. Sadick M, Schoenberg SO, Hoermann K and Sadick H: Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer. Laryngorhinootol 91(Suppl 1): S27-47, 2012.
41. Agarwal V, Branstetter BF 4th and Johnson JT: Indications for PET/CT in the head and neck. Otolaryngol Clin North Am 41: 23-49, 2008.
42. Kohlfurst S, Markitz M, Raunik W, Eckel HE, Kresnik E, Hausegger K, Salzwimmer M, Gaggl A, Chiari F and Lind P: Positron-emission tomography (PET) and PET/CT in head and neck cancer - recommendations of an interdisciplinary consensus conference. Laryngorhinootologie 88: 84-90, 2009.
43. Mabille L: Role of PET-CT in the follow-up of treated tumors of the head and neck. J Radiol 89: 1037-1040, 2008.
44. Teymoortash A and Werner JA: Current advances in diagnosis and surgical treatment of lymph node metastasis in head and neck cancer 91(Suppl 1): S102-22, 2012.